In fact, the level of caspase-3 was found to be reduced in tumor tissues compared with corresponding normal tissue in hepatocellular carcinoma [25], pancreatic cancer [19] and prostate carcinoma [26]. This evidence concerns the gene CASP3 and familial pancreatic carcinoma.